The $3.50 central target reflects a small but current analyst universe. Two covering analysts were reviewed: B. Riley Securities raised its target to $4.00 from $3.50 on September 22, 2026, keeping a Buy rating, while Maxim Group maintained a Buy rating with a $3.00 target in August 2026. The arithmetic mean of those two figures is $3.50, with a low-to-high range of $3.00 to $4.00. Because coverage is thin, the "average analyst price target" should be read cautiously rather than as a deep consensus.
The reasoning behind the Buy ratings is tied to the treasury structure itself. Analysts have focused on the growth of SOL per share, staking revenue, and the potential for the discount to net asset value (NAV) to narrow. Notably, the targets have moved both directions over 2026 — B. Riley cut its target to $2.50 in August before raising it back to $4.00 in September — underscoring how sensitive the price forecast is to crypto-market conditions. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to monitor shifting conditions.
As of the most recent close, HSDT traded near $1.93, giving the stock a market capitalization of roughly $117 million to $126 million. Reaching the $3.50 central target implies an upside of approximately 81%, which is a very large move by ordinary equity standards. The path depends less on conventional earnings growth than on the value of the company's SOL holdings, which were reported at a fair value of about $170.6 million as of June 30, 2026, and the multiple investors are willing to assign to those assets. The company has reported that it traded at roughly 0.81 times its market-value-to-net-asset-value (MNAV) ratio, meaning the shares sit below the estimated value of the underlying tokens.
Several verified factors support the bull case. The company reported a gross staking yield of about 6.14% APY in the second quarter of 2026, modestly above the network average, and it automatically restakes rewards to grow its SOL position per share. Management has also used share repurchases — roughly $2.3 million in the second quarter, retiring about 1.3 million shares — to offset dilution. A sustained rise in Solana's price, further accumulation of SOL, and any narrowing of the NAV discount would all mechanically lift the stock price target.
The principal risks are equally concrete. HSDT is effectively a leveraged proxy for Solana, so a decline in SOL prices flows directly through to the balance sheet and the stock. The company reported a GAAP net loss of about $30.3 million in the June 2026 quarter and carries a substantial number of outstanding warrants that can dilute existing holders. The shares have a beta near 1.7, indicating higher-than-average volatility, and the stock's persistent discount to NAV shows that the market has not consistently awarded full credit for the underlying tokens. Regulatory uncertainty around digital assets adds a further layer of risk.
HSDT has traded in a wide 52-week range of roughly $1.19 to about $5.77, according to Yahoo Finance, placing the recent $1.93 price in the lower portion of that band. The $3.00 and $4.00 analyst targets effectively map to psychological reference zones between the current price and the 52-week high, while the NAV discount acts as a structural anchor rather than a classic technical support level. Because the stock's movement is dominated by crypto pricing, traditional support and resistance levels are less reliable than they are for typical equities.
Analyst price targets generally reflect a research horizon of roughly 12 months, though the two firms' differing dates mean their targets may reflect slightly different snapshots of the Solana market. Investors should monitor Solana's token price, the company's reported SOL holdings and staking yield, the MNAV premium or discount, any new capital raises or buybacks, and dilution from warrant exercises. Upcoming quarterly results and any changes to analyst targets will also matter, given how frequently the targets have been revised.
In my research process, I have found Tickeron's AI Daily Buy/Sell Signals to be a practical way to track high-volatility names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and market shifts. For something as sensitive to crypto moves as HSDT, it helps surface opportunities and monitor positions more efficiently alongside my own analysis of holdings and NAV metrics.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HSDT moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend. In 26 of 27 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSDT as a result. In 70 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The 10-day moving average for HSDT crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HSDT entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSDT advanced for three days, in 171 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HSDT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. HSDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.688) is normal, around the industry mean (2.412). P/E Ratio (0.010) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.319). Dividend Yield (0.000) settles around the average of (0.270) among similar stocks. P/S Ratio (11.574) is also within normal values, averaging (15.694).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a medical technology company focused on neurological wellness
Industry InvestmentManagers